Skip to main content
Top
Published in: Immunologic Research 2-3/2019

01-06-2019 | Primary Immunodeficiency | Original Article

Immune reconstitution after HSCT in SCID—a cohort of conditioned and unconditioned patients

Authors: Uri Manor, Atar Lev, Amos J. Simon, Daphna Hutt, Amos Toren, Bella Bielorai, Lior Goldberg, Tali Stauber, Raz Somech

Published in: Immunologic Research | Issue 2-3/2019

Login to get access

Abstract

Allogeneic hematopoietic stem cell transplantation (HSCT) is the effective mean of immune restoration in severe combined immunodefiency (SCID). Usually, HSCT without cytoreductive conditioning is attempted. Nevertheless, conditioning procedures are still preferred in a subset of patients. Herein, we describe the immunological outcome in a cohort of conditioned and unconditioned patients, from diagnosis, through transplantation, to follow-up. This retrospective study was conducted on 17 patients with SCID (10 conditioned, 7 unconditioned) who later underwent HSCT. Immune reconstitution was assessed in the post-transplant year by quantification of T cell receptor excision circles (TRECs) and kappa-deleting recombination excision circles (KRECs), among additional laboratory and clinical evaluations. Unconditioned patients were diagnosed and transplanted earlier. TREC and KREC quantification showed a gradual increase in both groups, with higher levels in the conditioned group. Engraftment percentages differed drastically between groups, favoring the conditioned group. Unconditioned patients were significantly more dependent on intravenous immunoglobulins (IVIGs). One patient from each group succumbed to disease complications. Conditioning demonstrated superior laboratorial outcomes. Patients with unique characteristics (i.e., consanguinity, Bacillus Calmette–Guérin vaccination, impaired access to IVIG) may require personalized considerations. The effort to implement secondary prevention of SCID with newborn screening should continue.
Literature
1.
go back to reference Buckley RH. Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. Annu Rev Immunol. 2004;22:625–55.CrossRefPubMed Buckley RH. Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. Annu Rev Immunol. 2004;22:625–55.CrossRefPubMed
3.
go back to reference Szabolcs P, Cavazzana-Calvo M, Fischer A, Veys P. Bone marrow transplantation for primary immunodeficiency diseases. Pediatr Clin N Am. 2010;57:207–37.CrossRef Szabolcs P, Cavazzana-Calvo M, Fischer A, Veys P. Bone marrow transplantation for primary immunodeficiency diseases. Pediatr Clin N Am. 2010;57:207–37.CrossRef
4.
go back to reference Gaspar HB, Qasim W, Davies EG, Rao K, Amrolia PJ, Veys P. How I treat: how I treat severe combined immunodeficiency. Blood. 2013;122(23):3749–58.CrossRefPubMed Gaspar HB, Qasim W, Davies EG, Rao K, Amrolia PJ, Veys P. How I treat: how I treat severe combined immunodeficiency. Blood. 2013;122(23):3749–58.CrossRefPubMed
5.
go back to reference Lev A, Simon AJ, Bareket M, Bielorai B, Hutt D, Amariglio N, et al. The kinetics of early T and B cell immune recovery after bone marrow transplantation in RAG-2-deficient SCID patients. PLoS One. 2012;7(1):e30494.CrossRefPubMedPubMedCentral Lev A, Simon AJ, Bareket M, Bielorai B, Hutt D, Amariglio N, et al. The kinetics of early T and B cell immune recovery after bone marrow transplantation in RAG-2-deficient SCID patients. PLoS One. 2012;7(1):e30494.CrossRefPubMedPubMedCentral
6.
go back to reference Lee YN, Frugoni F, Dobbs K, Tirosh I, Du L, Ververs FA, et al. Characterization of T and B cell repertoire diversity in patients with RAG deficiency. Sci Immunol. 2016;1(6):pii:eaah6109 Lee YN, Frugoni F, Dobbs K, Tirosh I, Du L, Ververs FA, et al. Characterization of T and B cell repertoire diversity in patients with RAG deficiency. Sci Immunol. 2016;1(6):pii:eaah6109
7.
go back to reference Mensen A, Ochs C, Stroux A, Wittenbecher F, Szyska M, Imberti L, et al. Utilization of TREC and KREC quantification for the monitoring of early T- and B-cell neogenesis in adult patients after allogeneic hematopoietic stem cell transplantation. J Transl Med. 2013;11:188.CrossRefPubMedPubMedCentral Mensen A, Ochs C, Stroux A, Wittenbecher F, Szyska M, Imberti L, et al. Utilization of TREC and KREC quantification for the monitoring of early T- and B-cell neogenesis in adult patients after allogeneic hematopoietic stem cell transplantation. J Transl Med. 2013;11:188.CrossRefPubMedPubMedCentral
8.
go back to reference van Zelm MC, van der Burg M, Langerak AW, et al. PID comes full circle: applications of V(D) J recombination excision circles in research, diagnostics and newborn screening of primary immunodeficiency disorders. Front Immunol. 2011;2(12):1–9. van Zelm MC, van der Burg M, Langerak AW, et al. PID comes full circle: applications of V(D) J recombination excision circles in research, diagnostics and newborn screening of primary immunodeficiency disorders. Front Immunol. 2011;2(12):1–9.
9.
go back to reference Serana F, Chiarini M, Zanotti C, Sottini A, Bertoli D, Bosio A, et al. Use of V(D) J recombination excision circles to identify T- and B-cell defects and to monitor the treatment in primary and acquired immunodeficiencies. J Transl Med. 2013;11(1):119.CrossRefPubMedPubMedCentral Serana F, Chiarini M, Zanotti C, Sottini A, Bertoli D, Bosio A, et al. Use of V(D) J recombination excision circles to identify T- and B-cell defects and to monitor the treatment in primary and acquired immunodeficiencies. J Transl Med. 2013;11(1):119.CrossRefPubMedPubMedCentral
10.
go back to reference Hazenberg MD, Verschuren MC, Hamann D, Miedema F. Van Dogen JJM. T cell receptor excision circles as markers for recent thymic emigrants: basic aspects, technical approach, and guidelines for interpretation. J Mol Med. 2001;79:631–40.CrossRefPubMed Hazenberg MD, Verschuren MC, Hamann D, Miedema F. Van Dogen JJM. T cell receptor excision circles as markers for recent thymic emigrants: basic aspects, technical approach, and guidelines for interpretation. J Mol Med. 2001;79:631–40.CrossRefPubMed
12.
go back to reference Buño I, Nava P, Simón A, Gonzalez-Rivera M, Jimenez JL, Balsalobre P, et al. A comparison of fluorescent in situ hybridization and multiplex short tandem repeat polymerase chain reaction for quantifying chimerism after stem cell transplantation. Haematologica. 2005;90(10):1373–9.PubMed Buño I, Nava P, Simón A, Gonzalez-Rivera M, Jimenez JL, Balsalobre P, et al. A comparison of fluorescent in situ hybridization and multiplex short tandem repeat polymerase chain reaction for quantifying chimerism after stem cell transplantation. Haematologica. 2005;90(10):1373–9.PubMed
13.
go back to reference Griffith LM, Cowan MJ, Kohn DB, Notarangelo LD, Puck JM, Schultz KR, et al. Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: current status and critical needs. J Allergy Clin Immunol. 2008;122(6):1087–96.CrossRefPubMedPubMedCentral Griffith LM, Cowan MJ, Kohn DB, Notarangelo LD, Puck JM, Schultz KR, et al. Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: current status and critical needs. J Allergy Clin Immunol. 2008;122(6):1087–96.CrossRefPubMedPubMedCentral
14.
go back to reference Haddad E, Logan BR, Griffith LM, Buckley RH, Parrott RE, Prockop SE, et al. SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery. Blood. 2018;132(17):1737–49.CrossRefPubMed Haddad E, Logan BR, Griffith LM, Buckley RH, Parrott RE, Prockop SE, et al. SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery. Blood. 2018;132(17):1737–49.CrossRefPubMed
15.
go back to reference Grunebaum E, Mazzolari E, Porta F, Dallera D, Atkinson A, Reid B, et al. Bone marrow transplantation for severe combined immunodeficiency. JAMA. 2006;295(5):508–18.CrossRefPubMed Grunebaum E, Mazzolari E, Porta F, Dallera D, Atkinson A, Reid B, et al. Bone marrow transplantation for severe combined immunodeficiency. JAMA. 2006;295(5):508–18.CrossRefPubMed
16.
go back to reference Patel NC, Chinen J, Rosenblatt HM, Hanson IC, Krance RA, Paul ME, et al. Outcomes of severe combined immunodeficiency patients treated with hematopoietic stem cell transplantation with and without pre-conditioning. J Allergy Clin Immunol. 2009;124(5):1062–9.CrossRefPubMedPubMedCentral Patel NC, Chinen J, Rosenblatt HM, Hanson IC, Krance RA, Paul ME, et al. Outcomes of severe combined immunodeficiency patients treated with hematopoietic stem cell transplantation with and without pre-conditioning. J Allergy Clin Immunol. 2009;124(5):1062–9.CrossRefPubMedPubMedCentral
17.
go back to reference Pai SY, Logan BR, Griffith LM, Buckley RH, Parrott RE, Dvorak CC, et al. Transplantation outcomes for severe combined immunodeficiency 2000-2009. N Engl J Med. 2014;371:434–46.CrossRefPubMedPubMedCentral Pai SY, Logan BR, Griffith LM, Buckley RH, Parrott RE, Dvorak CC, et al. Transplantation outcomes for severe combined immunodeficiency 2000-2009. N Engl J Med. 2014;371:434–46.CrossRefPubMedPubMedCentral
18.
19.
go back to reference Rechavi E, Lev A, Simon AJ, Stauber T, Daas S, Saraf-Levy T, et al. First year of Israeli newborn screening for severe combined immunodeficiency—clinical achievements and insights. Front Immunol. 2017;8:1448.CrossRefPubMedPubMedCentral Rechavi E, Lev A, Simon AJ, Stauber T, Daas S, Saraf-Levy T, et al. First year of Israeli newborn screening for severe combined immunodeficiency—clinical achievements and insights. Front Immunol. 2017;8:1448.CrossRefPubMedPubMedCentral
20.
go back to reference Lipstein EA, Vorono S, Browning MF, Green NS, Kemper AR, Knapp AA, et al. Systematic evidence review of newborn screening and treatment of severe combined immunodeficiency. Pediatrics. 2010;125(5):e1226–35.CrossRefPubMed Lipstein EA, Vorono S, Browning MF, Green NS, Kemper AR, Knapp AA, et al. Systematic evidence review of newborn screening and treatment of severe combined immunodeficiency. Pediatrics. 2010;125(5):e1226–35.CrossRefPubMed
21.
go back to reference Marciano BE, Huang CY, Joshi G, Rezaei N, Costa-Carvalho B, Allwood Z, et al. BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policies. J Allergy Clin Immunol. 2014;133(4):1134–41.CrossRefPubMedPubMedCentral Marciano BE, Huang CY, Joshi G, Rezaei N, Costa-Carvalho B, Allwood Z, et al. BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policies. J Allergy Clin Immunol. 2014;133(4):1134–41.CrossRefPubMedPubMedCentral
22.
go back to reference Dalal I, Tasher D, Somech R, Etzioni A, Garti BZ, Lev D, et al. Novel mutations in RAG1/2 and ADA genes in Israeli patients presenting with T-B- SCID or Omenn syndrome. Clin Immunol. 2011;140(3):284–90.CrossRefPubMed Dalal I, Tasher D, Somech R, Etzioni A, Garti BZ, Lev D, et al. Novel mutations in RAG1/2 and ADA genes in Israeli patients presenting with T-B- SCID or Omenn syndrome. Clin Immunol. 2011;140(3):284–90.CrossRefPubMed
23.
go back to reference Al-Mousa H, Al-Saud B. Primary immunodeficiency diseases in highly consanguineous populations from Middle East and North Africa: epidemiology, diagnosis, and care. Front Immunol. 2017;8:678.CrossRefPubMedPubMedCentral Al-Mousa H, Al-Saud B. Primary immunodeficiency diseases in highly consanguineous populations from Middle East and North Africa: epidemiology, diagnosis, and care. Front Immunol. 2017;8:678.CrossRefPubMedPubMedCentral
24.
go back to reference Grunebaum E, Roifman CM. Bone marrow transplantation using HLA-matched unrelated donors for patients suffering from severe combined immunodeficiency. Hematol Oncol Clin North Am. 2011;25:63–73.CrossRefPubMed Grunebaum E, Roifman CM. Bone marrow transplantation using HLA-matched unrelated donors for patients suffering from severe combined immunodeficiency. Hematol Oncol Clin North Am. 2011;25:63–73.CrossRefPubMed
25.
go back to reference Haddad E, Leroy S, Buckley RH. B-cell reconstitution for SCID: should a conditioning regimen be used in SCID treatment? J Allergy Clin Immunol. 2013;131(4):994–1000.CrossRefPubMedPubMedCentral Haddad E, Leroy S, Buckley RH. B-cell reconstitution for SCID: should a conditioning regimen be used in SCID treatment? J Allergy Clin Immunol. 2013;131(4):994–1000.CrossRefPubMedPubMedCentral
26.
go back to reference Buckley RH. B-cell function in severe combined immunodeficiency after stem cell or gene therapy: a review. J Allergy Clin Immunol. 2010;125(2):790–7.CrossRefPubMedPubMedCentral Buckley RH. B-cell function in severe combined immunodeficiency after stem cell or gene therapy: a review. J Allergy Clin Immunol. 2010;125(2):790–7.CrossRefPubMedPubMedCentral
27.
go back to reference Heimall J, Logan BR, Cowan MJ, Notarangelo LD, Griffith LM, Puck JM, et al. Immune reconstitution and survival of 100 SCID patients post hematopoietic cell transplant: a PIDTC natural history study. Blood. 2017;130(25):2718–27.CrossRefPubMedPubMedCentral Heimall J, Logan BR, Cowan MJ, Notarangelo LD, Griffith LM, Puck JM, et al. Immune reconstitution and survival of 100 SCID patients post hematopoietic cell transplant: a PIDTC natural history study. Blood. 2017;130(25):2718–27.CrossRefPubMedPubMedCentral
28.
go back to reference Sottini A, Ghidini C, Zanotti C, Chiarini M, Caimi L, Lanfranchi A, et al. Simultaneous quantification of recent thymic T-cell and bone marrow B-cell emigrants in patients with primary immunodeficiency undergone to stem cell transplantation. Clin Immunol. 2010;136(2):217–27.CrossRefPubMed Sottini A, Ghidini C, Zanotti C, Chiarini M, Caimi L, Lanfranchi A, et al. Simultaneous quantification of recent thymic T-cell and bone marrow B-cell emigrants in patients with primary immunodeficiency undergone to stem cell transplantation. Clin Immunol. 2010;136(2):217–27.CrossRefPubMed
29.
go back to reference Antin JH, Childs R, Filipovich AH, Giralt S, Mackinnon S, Spitzer T, et al. Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings. Biol Blood Marrow Transplant. 2001;7(9):473–85.CrossRefPubMed Antin JH, Childs R, Filipovich AH, Giralt S, Mackinnon S, Spitzer T, et al. Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings. Biol Blood Marrow Transplant. 2001;7(9):473–85.CrossRefPubMed
30.
go back to reference Somech R. T-cell receptor excision circles in primary immunodeficiencies and other T-cell immune disorders. Curr Opin Allergy Clin Immunol. 2011;11(6):517–24.CrossRefPubMed Somech R. T-cell receptor excision circles in primary immunodeficiencies and other T-cell immune disorders. Curr Opin Allergy Clin Immunol. 2011;11(6):517–24.CrossRefPubMed
Metadata
Title
Immune reconstitution after HSCT in SCID—a cohort of conditioned and unconditioned patients
Authors
Uri Manor
Atar Lev
Amos J. Simon
Daphna Hutt
Amos Toren
Bella Bielorai
Lior Goldberg
Tali Stauber
Raz Somech
Publication date
01-06-2019
Publisher
Springer US
Published in
Immunologic Research / Issue 2-3/2019
Print ISSN: 0257-277X
Electronic ISSN: 1559-0755
DOI
https://doi.org/10.1007/s12026-019-09081-z

Other articles of this Issue 2-3/2019

Immunologic Research 2-3/2019 Go to the issue